Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-11

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for insulin lispro from Eli Lilly (Humalog). This action typically relates to labeling changes or expanded use, thou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)